Get started
Author

Tomokazu Kimura

Observed names: KIMURA, Tomokazu, Kimura Tomokazu, Kimura, Tomokazu, T KIMURA, T Kimura, T. Kimura, T., Kimura
Observed institutions: University of Tsukuba, Nagoya University Hospital, University of Tsukuba Hospital, Suita Municipal Hospital, Komaki City Hospital, Hitachi General Hospital, Nagoya University
ORCID: 0000-0003-1201-1260
Observed ORCID: 0000-0003-1201-1260
OpenAlex ID: A5090064249
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
2021 · Thomas Powles, Tibor Csőszi, et al. · The Lancet Oncology · 642
Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data
2010 · Tomoaki Miyagawa, Satoru Ishikawa, et al. · International Journal of Urology · 123
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
2019 · Shunji Takahashi, Motohide Uemura, et al. · Investigational New Drugs · 81
PDF
Tinea pedis outbreak in swimming pools in Japan
1997 · T Kamihama, T Kimura, et al. · Public Health · 80
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
2025 · Maria De Santis, Joan Palou Redorta, et al. · The Lancet · 77
Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future
2020 · Tomokazu Kimura, Hitoshi Ishikawa, et al. · Japanese Journal of Clinical Oncology · 34
Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians
2004 · A.E. Hegab, T. Sakamoto, et al. · Respiratory Medicine · 31
PDF
The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study
2019 · Jun Miyazaki, Mizuki Onozawa, et al. · BMC Urology · 28
PDF
Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy
2014 · Tomokazu Kimura, Mizuki Onozawa, et al. · International Journal of Urology · 25
Risk Factors for Intravesical Recurrence in Patients with High-grade T1 Bladder Cancer in the Second TUR Era
2013 · Ei-ichiro Takaoka, Yoshiyuki Matsui, et al. · Japanese Journal of Clinical Oncology · 20
PDF
Impact of Early Exposure to Simulation Program on Undergraduate Medical Students’ Interest in Urology
2021 · Tomokazu Kimura, Kosuke Kojo, et al. · Journal of Medical Education and Curricular Development · 19
Risk factors for chronic kidney disease after chemotherapy for testicular cancer
2012 · Hiromu Inai, Koji Kawai, et al. · International Journal of Urology · 19
Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial
2023 · Tomokazu Kimura, Hitoshi Ishikawa, et al. · International Journal of Radiation Oncology*Biology*Physics · 18
PDF
Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer
2016 · Ei-ichiro Takaoka, Jun Miyazaki, et al. · Japanese Journal of Clinical Oncology · 18
Glycoprotein non–metastatic melanoma protein B functions with growth factor signaling to induce tumorigenesis through its serine phosphorylation
2021 · Chen Wang, Yukari Okita, et al. · Cancer Science · 17
PDF
Concurrent Urothelial Carcinoma in the Renal Pelvis of an Allograft Kidney and Native Recipient Bladder: Evidence of Donor Origin
2014 · E.-i. Takaoka, J. Miyazaki, et al. · Japanese Journal of Clinical Oncology · 16
Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer
2012 · M. Onozawa, N. Miyanaga, et al. · Japanese Journal of Clinical Oncology · 16
Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model
2019 · Takayuki Yoshino, Jun Miyazaki, et al. · PLoS ONE · 15
PDF
Case Report: Molecular Characterization of Aggressive Malignant Retroperitoneal Solitary Fibrous Tumor: A Case Study
2021 · Haruna Nonaka, Shuya Kandori, et al. · Frontiers in Oncology · 14
A Case of Generalized Acanthosis Nigricans with Positive Lupus Erythematosus-Related Autoantibodies and Antimicrosomal Antibody: Autoimmune Acanthosis Nigricans
2012 · Y. Kondo, N. Umegaki, et al. · Case Reports in Dermatology · 13
A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma
2019 · Yoshiyuki Nagumo, Takahiro Kojima, et al. · International Journal of Clinical Oncology · 12
Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital‐Based Cancer Registry data in Japan
2021 · Masanobu Shiga, Yoshiyuki Nagumo, et al. · International Journal of Urology · 11
Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012–2015 hospital-based cancer registry data
2020 · Kosuke Kojo, Koji Kawai, et al. · Japanese Journal of Clinical Oncology · 11
Validation of the prognostic grouping of the seventh edition of the tumor‐nodes‐metastasis classification using a large‐scale prospective cohort study database of prostate cancer treated with primary androgen deprivation therapy
2013 · Tomokazu Kimura, Mizuki Onozawa, et al. · International Journal of Urology · 11
PDF
Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study
2021 · Yuta Sekino, Hitoshi Ishikawa, et al. · Contemporary Clinical Trials Communications · 10
PDF
Works count: 120
Citation count: 1,544
H-index: 16
I10-index: 25
Year
Topic
Type